Wisastra R et al. |
Discovery of a novel activator of 5-lipoxygenase from an anacardic acid derived compound collection. |
2013 |
Bioorg. Med. Chem. |
pmid:24231650
|
Wisastra R et al. |
Anacardic acid derived salicylates are inhibitors or activators of lipoxygenases. |
2012 |
Bioorg. Med. Chem. |
pmid:22789707
|
Wu J et al. |
Bisubstrate Inhibitors of the MYST HATs Esa1 and Tip60. |
2009 |
Bioorg. Med. Chem. |
pmid:19114310
|
Muroi H et al. |
Synergistic effects of anacardic acids and methicillin against methicillin resistant Staphylococcus aureus. |
2004 |
Bioorg. Med. Chem. |
pmid:14738968
|
Green IR et al. |
Molecular design of anti-MRSA agents based on the anacardic acid scaffold. |
2007 |
Bioorg. Med. Chem. |
pmid:17601740
|
Mamidyala SK et al. |
Efficient synthesis of anacardic acid analogues and their antibacterial activities. |
2013 |
Bioorg. Med. Chem. Lett. |
pmid:23416004
|
Kanojia RM et al. |
6-oxa isosteres of anacardic acids as potent inhibitors of bacterial histidine protein kinase (HPK)-mediated two-component regulatory systems. |
1999 |
Bioorg. Med. Chem. Lett. |
pmid:10571153
|
Hoellein A et al. |
Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma. |
2014 |
Blood |
pmid:25143484
|
Sung B et al. |
Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-kappaB-regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of the inhibitory subunit of nuclear factor-kappaBalpha kinase, leading to potentiation of apoptosis. |
2008 |
Blood |
pmid:18349320
|
Park M et al. |
Anacardic acid inhibits pancreatic cancer cell growth, and potentiates chemotherapeutic effect by Chmp1A - ATM - p53 signaling pathway. |
2018 |
BMC Complement Altern Med |
pmid:29463243
|